Evolving patient needs and market complexities are reshaping how support models are built and measured. This whitepaper offers insights and real-world strategies to help pharmaceutical teams adapt, optimize programs, and improve outcomes.

Avoid costly missteps with our proven solutions, backed by over 45 years of experience. You'll gain access to our worldwide distribution network, global expertise, and intimate understanding of local markets. We tailor every strategy to your product for faster speeds to market & greater confidence.

Since launching the first FDA-approved companion diagnostic 25 years ago, Agilent continues to deliver CDx solutions in close collaboration with our pharma partners worldwide. Our broad technical expertise, global infrastructure and decades of commercial experience make us a proven CDx partner.

Meet us at ASCO in Booth 36076 to discuss your CDx needs. 

Our latest whitepaper shows how researchers are exploring the effectiveness of combining antibody drug conjugates and immune checkpoint inhibitors in non-small cell lung cancer. Download now. 

This white paper explores three brand personas based on the current stage of their journey to omnichannel synchronization. It then explains how marketing leaders can empower change agents to progress further on the path, including the resources and KPIs they can use to track that progression and prove its value to the business.

Does your clinical trial involving a genetically modified product require Institutional Biosafety Committee (IBC) review? Download WCG’s case study to discover how a combined IBC and Institutional Review Board (IRB) process reduced timelines and streamlined communications for a leading CRO.